Results

Total Results: 426 records

Showing results for "design sample size".

341. Archived: Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/diabetes-mellitus-type-2-in-adults-screening-2003
     February 03, 2003 - Staff of the funding agency and members of the USPSTF contributed to the study design, reviewed draft … Design and methods for a clinical trial in the prevention of type 2 diabetes.

342. Screening for Speech and Language Delay and Disorders in Children 5 Years or Younger: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6tmQG7VgexjoXt7uNoyccj
     December 02, 2023 - only 1 Ineligible setting 1 Non–English-language 128 Ineligible/no comparison 97 Ineligible study design … Characteristics of Included Studies of Diagnostic Accuracy (KQ2) Source, setting Study design (No. of … Sure Start Language Measure; SST, Structured Screening Test; WIC, Women, Infants, and Children. a Full sample … size, based on multiple imputation. b Includes 11 children (10.5%) who did not cooperate during screening … Concept and design: Feltner, Wallace, Nowell, Raffa, Kahwati.

343. Evidence Summary: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-depression-suicide-risk-adults
     June 20, 2023 - Design: Study did not use an included design.

344. Evidence Summary: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
     August 22, 2023 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … quality except for 1 rated fair quality 43 due to unclear allocation concealment methods and open-label design … Otherwise, AHRQ had no role in the design and conduct of the study; collection, management, analysis, … and general populations of HIV-uninfected persons) No reporting bias detected Fair Retrospective design

345. Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Dofv_5wDUQYVkoSDbX6Zse
     May 25, 2021 - Study sample sizes ranged from 50 to 2261; the total number of participants in all included studies was

346. Screening for Suicide Risk in Adults: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cJSpoZqW2M7czx_-GeTdtE
     May 01, 2004 - Within each study design section, we provide the evidence stratified by age whenever possible. … Using a nested case-control design, Coryell et al evaluated suicide risk in a long-term cohort of patients … 4).26 Treatment duration and length of Number (%) of Follow-up Participants with Reported Study Design … intervention does not produce a statistically significant benefit, whereas studies that have larger sample … sizes typically provide the least intense (and, arguably, likely less efficacious) interventions.35

347. Kbjjfcap9Xvhkp43U-7B9Q (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
     July 01, 2014 - Characteristics of Studies of Antiviral Therapy Study, Year (Reference) Design Duration Country/Region … Sample Size, n Adefovir vs. placebo Hadziyannis et al, 2003 (22) RCT 48 wk Canada, Greece, Israel, … Table —Continued Study, Year (Reference) Design Duration Country/Region Sample Size, n Pegylated interferon … Author Contributions: Conception and design: R. Chou, J. Khangura, B. Zakher. … Excluded articles (n = 567) Wrong population: 94 Wrong intervention: 196 Wrong outcome: 83 Wrong study design

348. Archived: Drug Use, Illicit: Primary Care Interventions for Children and Adolescents | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
     March 11, 2014 - Although the interventions substantially varied in their intensity, components, populations, and sample … sizes, they provide almost no evidence of significant improvements in health outcomes.

349. Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/U7JR2xtrb6EHFyLP6yUTAK
     March 20, 2018 - Evidence is insufficient because of the limited number or size of studies. important flaws in study design

350. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
     October 01, 2009 - The Women’s Antioxidant Cardiovascular Study: design and baseline char- acteristics of participants. … low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design … Evidence is insufficient because of: the limited number or size of studies important flaws in study design

351. Screening for Hepatitis C Virus Infection in Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/WEqCV3NvnZAeLdC_pp6nVK
     October 01, 2018 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … Sample sizes ranged from 20 to 706, mean age ranged from 45 to 68 years, and the proportion of women … SVRafterantiviraltreatmentvsnoSVRandclinicaloutcomes(eTable15 in the Supplement).63-66,68-82,84-94 Sample … sizes ranged from 131 to 50 886 (total n = 116 659), mean age ranged from 42 to 69 years, and the proportion … Concept and design: Chou, Wagner, Jou.

352. Primary Care Interventions to Prevent Child Maltreatment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DPq7_eawq-Ts6XLowaTaNA
     November 27, 2018 - Extraction and Quality Assessment For each included study, 1 investigator extracted information about design … intervention 8 Ineligible comparison 79 Ineligible outcome 16 Ineligible setting 15 Ineligible study design … Concept and design: Viswanathan, Fraser, Forman- Hoffman, Hart, Zolotor, Jonas.

353. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
     February 13, 2018 - for KQ1 60 Articles excluded for KQ1 2 Aim 0 Setting 28 Outcomes 1 Population 0 Intervention 29 Design … Quality 59 Articles excluded for KQ2a 2 Aim 0 Setting 26 Outcomes 1 Population 0 Intervention 30 Design … Design: Study did not use an included design. Language: Publication not in English. … Concept and design: Henderson, Webber. … Otherwise, AHRQ had no role in the design and conduct of the study; collection, management, analysis,

354. Archived: Final Evidence Summary: Skin Cancer: Screening, April 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/skin-cancer-screening-2001
     April 01, 2001 - published studies of screening and recorded it in an electronic database: type of screening study, study design … explain the observed differences in outcome. 29 Apart from concerns about the strength of the study design

355. Secyfgzqgdoqdd8J4Ccvuy (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SEcYfGZqGdoqdd8j4CCVuy
     May 01, 2008 - Study design: RCT, CCT, observational 6. … [PMID: 6391174] Study design Coustan DR. … [PMID: 11247613] Study design De Muylder X. … [PMID: 11107459] Study design Greene MF. … [PMID: 15167862] Study design Kumar KM.

356. Archived: Final Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary26/gestational-diabetes-screening-2008
     May 15, 2008 - Study design: RCT, CCT, observational. … Study design: all considered. … Study design: all considered. … [PMID: 6391174] Study design Coustan DR. … [PMID: 15167862] Study design Kumar KM.

357. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - and Quality Assessment Investigators abstracted data from studies of risk assessment methods (study design … standards; risk factors included in the models; and performance measures) and trials of medications (study design

358. Pdf (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/588/gdart/pdf
     May 01, 2008 - Study design: RCT, CCT, observational 6. … [PMID: 6391174] Study design Coustan DR. … [PMID: 11247613] Study design De Muylder X. … [PMID: 11107459] Study design Greene MF. … [PMID: 15167862] Study design Kumar KM.

359. Screening and Treatment for Hypercholesterolemia in Children and Adolescents: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
     January 01, 2007 - • Handles indeterminate results in a reasonable manner • Spectrum of patients included in study • Sample … size • Administration of reliable screening test Definition of ratings based on above criteria: … although not best standard; interprets reference standard independent of screening test; moderate sample … size (50 to 100 subjects) and a “medium” spectrum of patients. … size of very narrow selected spectrum of patients.

360. Pzrh6M8Vucdvmsabwkaqa2 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Pzrh6m8vUcdvmsaBwKaQA2
     February 01, 2014 - Evidence is insufficient because of: the limited number or size of studies; important flaws in study design